Randomized Phase II Study with Cetuximab in Combination with 5-FU and Cisplatin or Carboplatin Vs. Cetuximab in Combination with Paclitaxel and Carboplatin for Treatment of Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck (CETMET Trial)

SIMPLE SUMMARY: The purpose of the CET-MET trial was to find a new platinum- based chemotherapy regimen in combination with cetuximab for relapsed or metastatic squamous cell carcinoma of the head and neck (RM- SCCHN), that would achieve an equivalent PFS with standard cetuximab and 5-FU/platinum-ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsakonas, Georgios, Specht, Lena, Kristensen, Claus Andrup, Moreno, Maria Herlestam Calero, Haugen Cange, Hedda, Soderstrom, Karin, Friesland, Signe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693024/
https://www.ncbi.nlm.nih.gov/pubmed/33114379
http://dx.doi.org/10.3390/cancers12113110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693024/
https://www.ncbi.nlm.nih.gov/pubmed/33114379
http://dx.doi.org/10.3390/cancers12113110

Ejemplares similares